文献速递呼吸衰竭与机械通气消化、代谢与肾脏急症

侵袭性疾病与尿抗原确诊的肺炎链球菌社区获得性肺炎比较

Invasive Disease vs Urinary Antigen-Confirmed Pneumococcal Community-Acquired Pneumonia.
PubMed 文献 · Chest · 2017-01-16
一句话结论尿抗原确诊的非侵袭性肺炎链球菌肺炎占54%,虽病情较轻但并非30天死亡独立危险因素,侵袭性诊断并非独立预后因素。

该前瞻性观察研究纳入2000年1月至2014年12月连续非免疫抑制社区获得性肺炎患者,按诊断方式分为侵袭性肺炎链球菌肺炎(血或胸水培养阳性)和非侵袭性(尿抗原阳性但培养阴性)。共分析779例(占5132例的15%),其中侵袭性361例(46%),非侵袭性418例(54%)。侵袭性组病情更重、炎症标志物更高、氧合更差、肺内外并发症更多、临床稳定时间和住院时间更长。但多因素分析显示侵袭性或非侵袭性均非30天死亡的独立危险因素;年龄、慢性肝病、机械通气和急性肾衰竭是独立危险因素。

要点

  • 尿抗原试验确诊的肺炎链球菌肺炎占全部肺炎链球菌肺炎的54%(418/779),提示其诊断价值重要。
  • 侵袭性肺炎链球菌肺炎患者病情更重:炎症标志物更高、氧合更差、并发症更多、住院时间更长。
  • 侵袭性诊断本身并非30天死亡的独立危险因素,年龄、慢性肝病、机械通气、急性肾衰竭才是独立危险因素。
  • 非免疫抑制社区获得性肺炎患者中,尿抗原阳性但培养阴性者应视为肺炎链球菌肺炎,不应因非侵袭性而低估。

适用人群与场景

  • 连续非免疫抑制的社区获得性肺炎患者,研究期间为2000年1月至2014年12月。

诊断标准与关键阈值

  • 侵袭性肺炎链球菌肺炎(IPP)定义为血培养或胸水培养阳性。
  • 非侵袭性肺炎链球菌肺炎(NIPP)定义为尿抗原试验阳性且血培养或胸水培养阴性。

研究设计与关键结果

  • 前瞻性观察研究,共分析779例(占5132例的15%),其中IPP 361例(46%),NIPP 418例(54%)。
  • 与NIPP组相比,IPP组就诊时社区获得性肺炎更严重、炎症标志物水平更高、氧合更差。
  • IPP组肺部并发症更多、肺外并发症更多、达到临床稳定的时间更长、住院时间更长。
  • NIPP组慢性肺病更常见、既往抗生素使用更频繁。
  • 年龄、慢性肝病、机械通气、急性肾衰竭是30天粗死亡率的独立危险因素。
  • IPP或NIPP均不是30天死亡率的独立危险因素。

证据类型、等级与局限

  • 证据类型:前瞻性观察研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,尽管IPP与NIPP在临床特征和结局上存在差异,但IPP并非30天死亡的独立危险因素,这强化了NIPP对肺炎链球菌肺炎的重要性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The burden of pneumococcal disease is measured only through patients with invasive pneumococcal disease. The urinary antigen test (UAT) for pneumococcus has exhibited high sensitivity and specificity. We aimed to compare the pneumococcal pneumonias diagnosed as invasive disease with pneumococcal pneumonias defined by UAT results.

METHODS: A prospective observational study of consecutive nonimmunosuppressed patients with community-acquired pneumonia was performed from January 2000 to December 2014. Patients were stratified into two groups: invasive pneumococcal pneumonia (IPP) defined as a positive blood culture or pleural fluid culture result and noninvasive pneumococcal pneumonia (NIPP) defined as a positive UAT result with negative blood or pleural fluid culture result.

RESULTS: We analyzed 779 patients (15%) of 5,132, where 361 (46%) had IPP and 418 (54%) had NIPP. Compared with the patients with IPP, those with NIPP presented more frequent chronic pulmonary disease and received previous antibiotics more frequently. Patients with IPP presented more severe community-acquired pneumonia, higher levels of inflammatory markers, and worse oxygenation at admission; more pulmonary complications; greater extrapulmonary complications; longer time to clinical stability; and longer length of hospital stay compared with the NIPP group. Age, chronic liver disease, mechanical ventilation, and acute renal failure were independent risk factors for 30-day crude mortality. Neither IPP nor NIPP was an independent risk factor for 30-day mortality.

CONCLUSIONS: A high percentage of confirmed pneumococcal pneumonia is diagnosed by UAT. Despite differences in clinical characteristics and outcomes, IPP is not an independent risk factor for 30-day mortality compared with NIPP, reinforcing the importance of NIPP for pneumococcal pneumonia.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Ceccato A, Torres A, Cilloniz C, et al. Invasive Disease vs Urinary Antigen-Confirmed Pneumococcal Community-Acquired Pneumonia. Chest. 2017. PMID: 28093269. doi:10.1016/j.chest.2017.01.005

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。